Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 57.06B | 57.52B | 56.04B | 55.05B | 49.85B | 42.48B |
Gross Profit | 10.97B | 11.14B | 9.73B | 9.94B | 9.77B | 7.54B |
EBITDA | 3.95B | 5.35B | 4.09B | 4.28B | 5.46B | 3.81B |
Net Income | 486.00M | 1.19B | 342.00M | -257.00M | 2.35B | 1.05B |
Balance Sheet | ||||||
Total Assets | 77.79B | 77.80B | 79.12B | 73.03B | 71.49B | 67.91B |
Cash, Cash Equivalents and Short-Term Investments | 7.22B | 8.71B | 8.28B | 8.29B | 11.52B | 12.75B |
Total Debt | 25.05B | 24.59B | 25.58B | 24.88B | 25.06B | 25.64B |
Total Liabilities | 41.45B | 41.01B | 42.44B | 40.75B | 40.24B | 38.81B |
Stockholders Equity | 30.63B | 30.72B | 31.16B | 26.89B | 26.42B | 22.99B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 954.00M | -1.47B | -1.83B | 811.00M | 1.09B |
Operating Cash Flow | 0.00 | 4.64B | 2.78B | 2.23B | 4.06B | 3.57B |
Investing Cash Flow | 0.00 | -2.81B | -2.84B | -4.48B | -3.34B | -2.47B |
Financing Cash Flow | 0.00 | -1.70B | -241.00M | -1.38B | -2.12B | 3.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥12.22B | 9.60 | 2.23% | 2.63% | 268.28% | ||
80 Outperform | ¥12.79B | 10.13 | 3.66% | -6.96% | -1.72% | ||
80 Outperform | ¥14.64B | 10.46 | 357.18% | 20.91% | 18.64% | ||
75 Outperform | ¥13.05B | 13.53 | 3.04% | 25.64% | ― | ||
65 Neutral | $10.81B | 15.65 | 5.50% | 1.89% | 3.10% | -27.09% | |
57 Neutral | ¥12.15B | 15.76 | 2.04% | 25.48% | ― | ||
54 Neutral | ¥12.68B | ― | 5.66% | -6.30% | 34.61% |